Peter S - Search Results

1

Molecular subtyping of bladder cancer using Kohonen self-organizing maps.

Borkowska EM, Kruk A, Jedrzejczyk A, Rozniecki M, Jablonowski Z, Traczyk M, Constantinou M, Banaszkiewicz M, Pietrusinski M, Sosnowski M, Hamdy FC, Peter S, Catto JW, Kaluzewski B. Borkowska EM, et al. Among authors: peter s. Cancer Med. 2014 Oct;3(5):1225-34. doi: 10.1002/cam4.217. Epub 2014 Aug 20. Cancer Med. 2014. PMID: 25142434 Free PMC article.

2

Identification of differentially expressed long noncoding RNAs in bladder cancer.

Peter S, Borkowska E, Drayton RM, Rakhit CP, Noon A, Chen W, Catto JW. Peter S, et al. Clin Cancer Res. 2014 Oct 15;20(20):5311-21. doi: 10.1158/1078-0432.CCR-14-0706. Epub 2014 Aug 27. Clin Cancer Res. 2014. PMID: 25165097

3

Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11.

Drayton RM, Dudziec E, Peter S, Bertz S, Hartmann A, Bryant HE, Catto JW. Drayton RM, et al. Among authors: peter s. Clin Cancer Res. 2014 Apr 1;20(7):1990-2000. doi: 10.1158/1078-0432.CCR-13-2805. Epub 2014 Feb 10. Clin Cancer Res. 2014. PMID: 24516043 Free PMC article.

4

MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer.

Drayton RM, Peter S, Myers K, Miah S, Dudziec E, Bryant HE, Catto JW. Drayton RM, et al. Among authors: peter s. Oncotarget. 2014 Aug 15;5(15):6375-86. doi: 10.18632/oncotarget.2221. Oncotarget. 2014. PMID: 25071007 Free PMC article.

5

Comparison of microfluidic platforms for the enrichment of circulating tumor cells in breast cancer patients.

Sajdik C, Schuster E, Holzer B, Krainer M, Deutschmann C, Peter S, Marhold M, Zeillinger R, Obermayr E. Sajdik C, et al. Among authors: peter s. Breast Cancer Res Treat. 2022 Nov;196(1):75-85. doi: 10.1007/s10549-022-06717-x. Epub 2022 Sep 8. Breast Cancer Res Treat. 2022. PMID: 36074219 Free PMC article.

6

Proteomic analysis of the impact of static culturing on the expansion of rat bone marrow mesenchymal stem cells.

Peter S, Evans C, Ow SY, Scutt AM, Wright PC, Biggs CA. Peter S, et al. Biotechnol Lett. 2012 Aug;34(8):1589-96. doi: 10.1007/s10529-012-0935-2. Epub 2012 May 8. Biotechnol Lett. 2012. PMID: 22566207

7

Multiple drug resistance gene expression in human renal cell cancer is associated with the histologic subtype.

Rochlitz CF, Lobeck H, Peter S, Reuter J, Mohr B, de Kant E, Huhn D, Herrmann R. Rochlitz CF, et al. Among authors: peter s. Cancer. 1992 Jun 15;69(12):2993-8. doi: 10.1002/1097-0142(19920615)69:12<2993::aid-cncr2820691222>3.0.co;2-v. Cancer. 1992. PMID: 1350506

8

Identification of gene expression profiles in HeLa cells and HepG2 cells infected with Coxsackievirus B3.

Rassmann A, Martin U, Saluz HP, Peter S, Munder T, Henke A. Rassmann A, et al. Among authors: peter s. J Virol Methods. 2013 Jan;187(1):190-4. doi: 10.1016/j.jviromet.2012.08.025. Epub 2012 Sep 21. J Virol Methods. 2013. PMID: 23000448

9

Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.

Weidner U, Peter S, Strohmeyer T, Hussnätter R, Ackermann R, Sies H. Weidner U, et al. Among authors: peter s. Cancer Res. 1990 Aug 1;50(15):4504-9. Cancer Res. 1990. PMID: 1973362

10

Implementing microwell slides for detection and isolation of single circulating tumor cells from complex cell suspensions.

Yang L, Rivandi M, Franken A, Hieltjes M, van der Zaag PJ, Nelep C, Eberhardt J, Peter S, Niederacher D, Fehm T, Neubauer H. Yang L, et al. Among authors: peter s. Cytometry A. 2022 Dec;101(12):1057-1067. doi: 10.1002/cyto.a.24660. Epub 2022 Jun 14. Cytometry A. 2022. PMID: 35698878 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

858 results

Search Page

Filters